The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
The Lead
FDA Investigates Zyprexa Relprevv Patient Deaths
June 18, 2013 1:31 pm | by The Associated Press | News | Comments
Federal regulators are investigating the deaths of two patients who received injections of a longer-lasting version of Eli Lilly's antipsychotic Zyprexa. The Food and Drug Administration said Tuesday that the patients died three to four days after receiving an appropriate dose of the drug known...
Mississippi AG Hood Will Subpoena Google on Drug Sales
June 19, 2013 8:10 am | by JEFF AMY,Associated Press | News | Comments
Mississippi's attorney general says he still considers Google's responses to allegations that it...
Study: Wiser Medication Use Could Cut Health Costs
June 19, 2013 8:02 am | by LINDA A. JOHNSON,AP Business Writer | News | Comments
If doctors and patients used prescription drugs more wisely, they could save the U.S. health...
Arkansas AG Seeks to Uphold Verdict Against J&J
June 18, 2013 8:20 pm | by ANDREW DeMILLO - Associated Press - Associated Press | News | Comments
Arkansas' attorney general filed a brief Tuesday backed by his counterparts in 35 other states...
FREE Daily Email Newsletter
Obesity a Disease, Says American Medical Association
June 19, 2013 8:35 am | Videos | CommentsThe American Medical Association is recognizing obesity as a disease. Dr. Lou Aronne, an obesity specialist at New York Presbyterian Hospital, talks about the significance of this change and what it means for health care costs, awareness and prevention.
Don't Take Vitamins, Doctor Warns in New Book
June 19, 2013 8:28 am | Videos | CommentsAmericans spend $34 billion a year on vitamins, supplements and alternative therapies. Now, a new book debunks treatments that may not really work. Dr. Paul Offit of the Children's Hospital of Philadelphia discusses his book, "Do You Believe in Magic?"
Protalix Signs Supply Deal with Brazilian Government
June 19, 2013 7:58 am | by The Associated Press | News | CommentsShares of Protalix BioTherapeutics jumped in premarket trading Wednesday after the company announced a deal that requires the Brazilian government to buy at least $280M of the company's Gaucher disease treatment. The Israeli company said an arm of the Brazilian Ministry of Health has committed to buying at least $40M of the drug annually during the seven-year agreement for Uplyso.
Disposable Respirators
June 18, 2013 3:47 pm | Product Releases | CommentsTruAir’s broad-spectrum protection — NIOSH approved N95, N99, and P100 level protection — have made the entire TruAir line extremely popular in myriad industries. TruAir and TruAir Plus, NIOSH approved N95 and N99-level protection respectively, feature a similar design with a large, molded shell to aid in the reduction of breathing resistance.
Blister Package
June 18, 2013 3:30 pm | Product Releases | CommentsThe "smart" blister package, Ecoslide-RX® with integrated Med-ic® technology is senior friendly and child-resistant. Ideal for clinical trials where dosing data should be precisely recorded, Ecoslide-RX with Med-ic incorporates an electronic module and printed sensor grid inside the package, both of which are invisible to the patient.
Tablet Counter
June 18, 2013 3:12 pm | Product Releases | CommentsThe PPS SuperCount is a tablet counter operating at speeds up to 160 bottles per minute (24 track counter), and the new design features maximize efficiency while minimizing downtime. The vibrator trays have been redesigned to make them lighter which results in better response to vibration and faster, smoother product movement into the count eyes for a more precise product feed.
Ribbon Blenders
June 18, 2013 2:28 pm | Product Releases | CommentsOver 80 ribbon blenders, sized for different working volumes and bulk densities, are now available. Built-to-order custom units are also offered with fast lead times like the pictured 10-cu.ft. sanitary ribbon blender featuring 150-grit stainless steel 316 internal and external surfaces, bottom discharge extruder, lantern rings, spray bar system with atomizing nozzles, load cells and a NEMA 4X Ross SysCon control panel.
Dry Scroll Vacuum Pumps
June 18, 2013 11:54 am | Product Releases | CommentsThe nXDS-C features the Chemraz® exhaust valve which is used for applications involving pumping organic solvents or other materials that may attack the standard pumps’ fluroelastomer exhaust valve, causing it to deteriorate rapidly.
AMRI Burlington Receives DEA Approval to Handle Controlled Substances
June 18, 2013 10:59 am | News | CommentsAMRI announced today that its Burlington, Mass., site has received approval to expand its current U.S. Drug Enforcement Administration (DEA) registration to handle Schedule 2 and 2N controlled substances. The license represents the DEA’s acknowledgement of Burlington’s physical security and quality systems, including inventory control and documentation.
Royalty Pharma Lets Elan Takeover Bid Expire
June 18, 2013 9:37 am | by TOM MURPHY,AP Business Writer | News | CommentsRoyalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer. Royalty offered earlier this month to pay $13 per share for each Elan share plus up to $2.50 per share in payments based on performance milestones. That totaled about $7.76 billion not counting the milestone payments.
AstraZeneca Selects Location for New Global R&D Centre and Corporate Headquarters in Cambridge, UK
June 18, 2013 9:03 am | News | CommentsAstraZeneca today announced that its new UK-based global research and development centre and corporate headquarters will be located at the Cambridge Biomedical Campus on the southern outskirts of the city. By 2016, the new site will house a highly-skilled workforce of approximately 2,000.
Preparing for a Pandemic
June 18, 2013 8:29 am | Videos | CommentsMary Mahoney, North Shore Long Island Jewish Medical director of Emergency Planning and Preparedness, discusses the steps her hospital system is taking to prepare for a possible pandemic. In light of recent outbreaks around the globe pandemic preparation is becoming more important than ever.
Royalty Pharma Announces Withdrawal of Judicial Review and Lapse of Offer
June 18, 2013 8:11 am | News | CommentsRoyalty Pharma announced today that it had withdrawn its request for a judicial review of the Irish Takeover Panel's decision requiring it to lapse its offer for Elan Corporation, plc if, among other things, Elan shareholders approved the Share Repurchase Program.
Report: Slowdown in Health Care Costs to Continue
June 18, 2013 8:07 am | by RICARDO ALONSO-ZALDIVAR,Associated Press | News | CommentsThere's good news for most companies that provide health benefits for their employees: America's slowdown in medical costs may be turning into a trend, rather than a mere pause. A report Tuesday from accounting and consulting giant PwC projects lower overall growth in medical costs for next year, even as the economy gains strength and millions of uninsured people receive coverage under President Barack Obama's health care law.
Valeant Pharma Plans $1.75B Stock Offering
June 17, 2013 4:53 pm | by The Associated Press | News | CommentsCanadian drugmaker Valeant Pharmaceuticals International Inc. said Monday it will sell $1.75 billion in stock to help fund its acquisition of Bausch + Lomb. Valeant did not say how many shares it plans to sell. The company said it plans to raise $1.75 billion before discounts, expenses, and other...
